Pharmacokinetic Interaction Study in Indonesian Tuberculosis Patients Indonesia

NCT00306319 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis

Interventions

DRUG: moxifloxacin

Sponsor

Radboud University Medical Center